| NET LOSS PER SHARE
Presented in the table below is a reconciliation of the numerator and denominator for the basic and diluted earnings per share (“EPS”) calculations for the periods ended:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
| (In thousands, USD, except share and per share amounts) |
2023 |
|
2022 |
|
|
|
|
| Numerator: |
|
|
|
|
|
|
|
| Net loss |
$ |
(18,490) |
|
|
$ |
(11,572) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Denominator: |
|
|
|
|
|
|
|
| Weighted average common shares outstanding |
|
|
|
|
|
|
|
| Basic (in number) |
76,524,735 |
|
|
74,040,261 |
|
|
|
|
|
| Diluted (in number) |
76,524,735 |
|
|
74,040,261 |
|
|
|
|
|
| Net loss per unit |
|
|
|
|
|
|
|
| Basic |
$ |
(0.24) |
|
|
$ |
(0.16) |
|
|
|
|
|
| Diluted |
$ |
(0.24) |
|
|
$ |
(0.16) |
|
|
|
|
|
The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
| (Number of shares) |
March 31, |
|
|
|
2023 |
|
2022 |
|
|
|
|
| Common stock issued under the Backstop Agreement |
9,600,031 |
|
|
9,600,031 |
|
|
|
|
|
| Restricted stock grants with only service conditions |
4,529,117 |
|
|
3,108,277 |
|
|
|
|
|
| Private placement warrants |
272,779 |
|
|
272,779 |
|
|
|
|
|
|